Clinical trials in Bialystok – page 21

575 clinical trials in Bialystok, Poland across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Bialystok at a glance

575

clinical trials

Research sites9

Quick filters

575 trials in Bialystok

Open in trial search

Dementia Alzheimer's type

Not yet recruiting

Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Investigational

Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
Sponsor:Prinnovation GmbH

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

Registered drugNo placebo

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years
Substances:Busulfan
Sponsor:GPOH gGmbH

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Registered drug

Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)
Sponsor:Biogen Idec Research Limited

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drug

Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Eli Lilly & Co.

Contact Research Centre

Malignant melanoma

Not yet recruiting

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Melanoma

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Acute myeloid leukaemia+1

Not yet recruiting

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Registered drugNo placebo

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Cytarabine
Sponsor:GPOH gGmbH

Contact Research Centre

Sarcoidosis

Not yet recruiting

Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

Registered drug

Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Prednisolone
Sponsor:Xentria Inc.

Contact Research Centre

Gastrooesophageal reflux disease+1

Not recruiting

Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

Registered drug

Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Lansoprazole
Sponsor:Cinclus Pharma Holding AB (publ)

Contact Research Centre

Obesity

Not recruiting

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Metsera Inc.

Contact Research Centre

Obesity

Not recruiting

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational

A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Metsera Inc.

Contact Research Centre

Cardiovascular disorder

Not recruiting

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Bialystok

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on bladder cancer treatment using combination therapies, and innovative approaches for advanced breast cancer management. Research includes novel treatments for various solid tumors and gynecological malignancies.

Non-muscle invasive bladder cancer treatment
Advanced/metastatic breast cancer therapies
Gynecological tumor treatments

Investigations emphasize combination therapies and targeted treatment approaches.

02 Neurological & Mental Health

Clinical research targeting early Alzheimer's disease, exploring new treatments to slow disease progression and improve cognitive function.

Alzheimer's disease progression
Cognitive function assessment
Disease-modifying therapies

Focus on developing interventions for early-stage neurological conditions.

03 Inflammatory Conditions

Comprehensive studies on various inflammatory conditions including psoriatic arthritis, plaque psoriasis, and Crohn's disease. Research spans both biologic-naive and experienced patients.

Moderate to severe plaque psoriasis
Active psoriatic arthritis treatments
Chronic rhinosinusitis management

Evaluating novel therapeutic approaches for inflammatory disorders.

04 Metabolic & Cardiovascular Health

Studies addressing obesity, chronic kidney disease, and heart failure prevention. Research includes innovative treatments for weight management and cardiovascular risk reduction.

Obesity and weight management
Heart failure prevention
Chronic kidney disease treatments

Integration of multiple therapeutic approaches for complex metabolic conditions.

Back to Poland All countries